E
NUTX

Ergoteles’s Nutex Health NUTX Stock Holding History

Ergoteles’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,342
Closed -$84.9K – 578
2023
Q2 		$84.9K Buy
+1,342
New +$115K ﹤0.01% 925
2022
Q4 		– Sell
-5,445
Closed -$1.23M – 1749
2022
Q3 		$1.23M Buy
5,445
+2,710
+99% +$1.15M 0.04% 412
2022
Q2 		$1.32M Buy
+2,735
New +$3.22M 0.04% 431

Other funds holding NUTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $498M AUM 20.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Ergoteles's NUTX Position: Q3 2023 in Review

Ergoteles sold out of Nutex Health (NUTX) in Q3 2023, closing a stake of 1,342 shares — an estimated $84.9K sold.

Ergoteles first reported a position in NUTX in Q2 2022 and held it in 3 quarters. The position peaked at $1.32M in Q2 2022. 59 funds tracked by Wall St. Rank hold NUTX as of Q3 2023.

  • Ergoteles reported no remaining Nutex Health position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 1,342 Nutex Health shares in Q3 2023, an estimated $84.9K.
  • Ergoteles first reported a position in Nutex Health in Q2 2022 and held it in 3 quarters.
  • Ergoteles's Nutex Health position peaked at $1.32M in Q2 2022.
  • 59 funds tracked by Wall St. Rank held Nutex Health as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.